What is Hayat Pharmaceutical Industries Co Days Payable?
Hayat Pharmaceutical Industries CoAMM:HPIC 77 Days Payable is 125.23 as of Mar. 2026, which is 4% above its 10-year median of 120.83. GuruFocus rates AMM:HPIC with a GF Score™ of 77/100 and a GF Value™ of JOD2.74 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 922 Drug Manufacturers companies, Hayat Pharmaceutical Industries Co ranks worse than 50.22% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hayat Pharmaceutical Industries Co Days Payable Chart
AMM:HPIC vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hayat Pharmaceutical Industries Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Hayat Pharmaceutical Industries Co's Days Payable falls into.
Hayat Pharmaceutical Industries Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a Days Payable of 125.23 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hayat Pharmaceutical Industries Co and its competitors. This is near median its historical median of 120.83. Over the past decade, Hayat Pharmaceutical Industries Co's Days Payable has ranged from 56.43 to 187.12. According to the industry distribution chart, Hayat Pharmaceutical Industries Co ranks #463 out of 922 companies in the Drug Manufacturers industry, placing it in the top 50.2%.
Is Hayat Pharmaceutical Industries Co's Days Payable too high?
Hayat Pharmaceutical Industries Co's current Days Payable of 125.23 is near median its 10-year median of 120.83. Over the past 10 years, this metric has ranged from a low of 56.43 to a high of 187.12. The Drug Manufacturers industry median Days Payable is 90.84. Hayat Pharmaceutical Industries Co's value of 125.23 is 37.9% above this industry median. Based on the distribution chart, Hayat Pharmaceutical Industries Co ranks #463 out of 922 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hayat Pharmaceutical Industries Co ranks #463 out of 922 companies for Days Payable. This places Hayat Pharmaceutical Industries Co in the lower half of its industry. The industry median Days Payable is 90.84. Hayat Pharmaceutical Industries Co's value of 125.23 is 37.9% above this benchmark. Historically, Hayat Pharmaceutical Industries Co's own Days Payable has ranged from 56.43 to 187.12 over the past decade. While the company's 10-year median is 120.83 vs. the industry median of 90.84, Hayat Pharmaceutical Industries Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hayat Pharmaceutical Industries Co's current Days Payable of 125.23 is 37.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hayat Pharmaceutical Industries Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hayat Pharmaceutical Industries Co's current Days Payable is 125.23, which is near median its own 10-year median of 120.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co (AMM:HPIC) is currently considered Modestly Overvalued. The stock's GF Value™ is JOD2.74, compared to a current price of JOD3.13 — trading 14.2% above its estimated fair value. The current Days Payable is 125.23, which is near median its 10-year median of 120.83 and 37.9% above the Drug Manufacturers industry median of 90.84. Hayat Pharmaceutical Industries Co's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current Days Payable is 125.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hayat Pharmaceutical Industries Co (AMM:HPIC) Overvalued in 2026?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co stock appears to be overvalued.
The current stock price of JOD3.13 is trading 14.2% above its estimated GF Value™ of JOD2.74.
GuruFocus considers Hayat Pharmaceutical Industries Co to be Modestly Overvalued.
Key valuation signals for AMM:HPIC:
Days Payable: 125.23 (near median its 10-year median of 120.83)
GF Value™: JOD2.74 vs. price of JOD3.13 (14.2% above fair value)
Industry Position: 37.9% above the Drug Manufacturers median (#463 of 922)
No single metric tells the full story. See the AMM:HPIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hayat Pharmaceutical Industries Co Business Description
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
77GF Score
Get the complete analysis for AMM:HPIC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:HPIC has been successfully added to your 
